Stoke Therapeutics, Inc.与渤健公司宣布,将在第36届国际癫痫大会上展示其药物Zorevunersen用于潜在治疗Dravet综合征的临床研究数据。
Stoke Therapeutics, Inc.与渤健公司宣布,将在第36届国际癫痫大会上展示其药物Zorevunersen用于潜在治疗Dravet综合征的临床研究数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.